Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06157541
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2023-11-26
Brief Title:
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
Sponsor:
Queensland Institute of Medical Research
Organization:
Queensland Institute of Medical Research
Organization Data
Organization:
Queensland Institute of Medical Research
Class:
OTHER
Study ID:
P3894 MSD-MK3475-E78
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Queensland Institute of Medical Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Austin Hospital Melbourne Australia | OTHER |
| CUREator | UNKNOWN |
| Merck Sharp Dohme LLC | INDUSTRY |
| The Newro Foundation | UNKNOWN |
| Royal Brisbane and Womens Hospital | OTHER_GOV |
| Princess Alexandra Hospital Brisbane Australia | OTHER |